Avidity Biosciences (RNA)

• Market cap: $10.7B
• 1 day: 0.03%
• 5 days: 1.5%
• 1 month: 44.69%
• 3 months: 53.5%
• 6 months: 137.08%
• Year to date: 127.2%
• 1 year: 34.93%
• 5 years: 142.6%
• 10 years: 148.56%
• Sector: Healthcare
• Industry: Biotechnology

About: Avidity Biosciences Inc is a biopharmaceutical company committed to delivering a new class of RNA therapeutics called Antibody Oligonucleotide Conjugates, or AOCs. Company's pipeline currently has three programs in potentially registrational clinical trials: DM1, FSHD, and DMD. The segments includes following: Del-zota for DMD44, Del-desiran for DM1, Del-brax for FSHD.

Employees: 391